Clinical significance of intragraft miR-122 and -155 expression after liver transplantation

Tadafumi Asaoka, Dayami Hernandez, Panagiotis Tryphonopoulos, Akin Tekin, Jennifer Garcia, Seigo Nishida, Ji Fan, Thiago Beduschi, Rodrigo Vianna, Phillip Ruiz

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aim: Recurrent hepatitis C (RHC) and acute cellular rejection (AR) remain critical problems following liver transplantation (LT) in hepatitis C virus (HCV) positive recipients because of the similar clinical features. Discrimination between these conditions can be problematic, and adjunctive biomarkers would be useful to discriminate these processes. The aim of our study was to investigate the possibility of the intragraft miR-122 and -155 expression as new biomarkers after LT. Methods: A total of 29 HCV positive recipients were enrolled in this study. Intragraft expressions of miR-122 and -155 were studied between RHC predominant (n=17) and AR predominant cases (n=12) using quantitative reverse transcription polymerase chain reaction. Furthermore, we investigated the correlations between these expression levels and clinical serum parameters. Results: Intragraft miR-122 expression had a good correlation with serum alkaline phosphatase (P=0.02), but it was not correlated with the serum HCV viral load. The expression levels of miR-122 in the AR group were significantly higher than those in the RHC group (P=0.0006) and, inversely, the expression levels of miR-155 in the AR group were significantly lower than those in the RHC group (P=0.01). Conclusion: Our study emphasizes a useful pattern of miR-122 and -155 as ancillary markers to discriminate AR predominant cases from RHC in HCV positive patients after LT.

Original languageEnglish (US)
Pages (from-to)898-905
Number of pages8
JournalHepatology Research
Volume45
Issue number8
DOIs
StatePublished - Aug 1 2015

Fingerprint

Hepatitis C
Liver Transplantation
Hepacivirus
Biomarkers
Serum
Viral Load
Reverse Transcription
Alkaline Phosphatase
Polymerase Chain Reaction

Keywords

  • Acute cellular rejection
  • Hepatitis C
  • Liver transplantation
  • MiRNA
  • Molecular biomarker

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases

Cite this

Clinical significance of intragraft miR-122 and -155 expression after liver transplantation. / Asaoka, Tadafumi; Hernandez, Dayami; Tryphonopoulos, Panagiotis; Tekin, Akin; Garcia, Jennifer; Nishida, Seigo; Fan, Ji; Beduschi, Thiago; Vianna, Rodrigo; Ruiz, Phillip.

In: Hepatology Research, Vol. 45, No. 8, 01.08.2015, p. 898-905.

Research output: Contribution to journalArticle

Asaoka, Tadafumi ; Hernandez, Dayami ; Tryphonopoulos, Panagiotis ; Tekin, Akin ; Garcia, Jennifer ; Nishida, Seigo ; Fan, Ji ; Beduschi, Thiago ; Vianna, Rodrigo ; Ruiz, Phillip. / Clinical significance of intragraft miR-122 and -155 expression after liver transplantation. In: Hepatology Research. 2015 ; Vol. 45, No. 8. pp. 898-905.
@article{a89ab2ac556048c4b5ec28ce23fa0ef2,
title = "Clinical significance of intragraft miR-122 and -155 expression after liver transplantation",
abstract = "Aim: Recurrent hepatitis C (RHC) and acute cellular rejection (AR) remain critical problems following liver transplantation (LT) in hepatitis C virus (HCV) positive recipients because of the similar clinical features. Discrimination between these conditions can be problematic, and adjunctive biomarkers would be useful to discriminate these processes. The aim of our study was to investigate the possibility of the intragraft miR-122 and -155 expression as new biomarkers after LT. Methods: A total of 29 HCV positive recipients were enrolled in this study. Intragraft expressions of miR-122 and -155 were studied between RHC predominant (n=17) and AR predominant cases (n=12) using quantitative reverse transcription polymerase chain reaction. Furthermore, we investigated the correlations between these expression levels and clinical serum parameters. Results: Intragraft miR-122 expression had a good correlation with serum alkaline phosphatase (P=0.02), but it was not correlated with the serum HCV viral load. The expression levels of miR-122 in the AR group were significantly higher than those in the RHC group (P=0.0006) and, inversely, the expression levels of miR-155 in the AR group were significantly lower than those in the RHC group (P=0.01). Conclusion: Our study emphasizes a useful pattern of miR-122 and -155 as ancillary markers to discriminate AR predominant cases from RHC in HCV positive patients after LT.",
keywords = "Acute cellular rejection, Hepatitis C, Liver transplantation, MiRNA, Molecular biomarker",
author = "Tadafumi Asaoka and Dayami Hernandez and Panagiotis Tryphonopoulos and Akin Tekin and Jennifer Garcia and Seigo Nishida and Ji Fan and Thiago Beduschi and Rodrigo Vianna and Phillip Ruiz",
year = "2015",
month = "8",
day = "1",
doi = "10.1111/hepr.12424",
language = "English (US)",
volume = "45",
pages = "898--905",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Clinical significance of intragraft miR-122 and -155 expression after liver transplantation

AU - Asaoka, Tadafumi

AU - Hernandez, Dayami

AU - Tryphonopoulos, Panagiotis

AU - Tekin, Akin

AU - Garcia, Jennifer

AU - Nishida, Seigo

AU - Fan, Ji

AU - Beduschi, Thiago

AU - Vianna, Rodrigo

AU - Ruiz, Phillip

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Aim: Recurrent hepatitis C (RHC) and acute cellular rejection (AR) remain critical problems following liver transplantation (LT) in hepatitis C virus (HCV) positive recipients because of the similar clinical features. Discrimination between these conditions can be problematic, and adjunctive biomarkers would be useful to discriminate these processes. The aim of our study was to investigate the possibility of the intragraft miR-122 and -155 expression as new biomarkers after LT. Methods: A total of 29 HCV positive recipients were enrolled in this study. Intragraft expressions of miR-122 and -155 were studied between RHC predominant (n=17) and AR predominant cases (n=12) using quantitative reverse transcription polymerase chain reaction. Furthermore, we investigated the correlations between these expression levels and clinical serum parameters. Results: Intragraft miR-122 expression had a good correlation with serum alkaline phosphatase (P=0.02), but it was not correlated with the serum HCV viral load. The expression levels of miR-122 in the AR group were significantly higher than those in the RHC group (P=0.0006) and, inversely, the expression levels of miR-155 in the AR group were significantly lower than those in the RHC group (P=0.01). Conclusion: Our study emphasizes a useful pattern of miR-122 and -155 as ancillary markers to discriminate AR predominant cases from RHC in HCV positive patients after LT.

AB - Aim: Recurrent hepatitis C (RHC) and acute cellular rejection (AR) remain critical problems following liver transplantation (LT) in hepatitis C virus (HCV) positive recipients because of the similar clinical features. Discrimination between these conditions can be problematic, and adjunctive biomarkers would be useful to discriminate these processes. The aim of our study was to investigate the possibility of the intragraft miR-122 and -155 expression as new biomarkers after LT. Methods: A total of 29 HCV positive recipients were enrolled in this study. Intragraft expressions of miR-122 and -155 were studied between RHC predominant (n=17) and AR predominant cases (n=12) using quantitative reverse transcription polymerase chain reaction. Furthermore, we investigated the correlations between these expression levels and clinical serum parameters. Results: Intragraft miR-122 expression had a good correlation with serum alkaline phosphatase (P=0.02), but it was not correlated with the serum HCV viral load. The expression levels of miR-122 in the AR group were significantly higher than those in the RHC group (P=0.0006) and, inversely, the expression levels of miR-155 in the AR group were significantly lower than those in the RHC group (P=0.01). Conclusion: Our study emphasizes a useful pattern of miR-122 and -155 as ancillary markers to discriminate AR predominant cases from RHC in HCV positive patients after LT.

KW - Acute cellular rejection

KW - Hepatitis C

KW - Liver transplantation

KW - MiRNA

KW - Molecular biomarker

UR - http://www.scopus.com/inward/record.url?scp=84937520760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937520760&partnerID=8YFLogxK

U2 - 10.1111/hepr.12424

DO - 10.1111/hepr.12424

M3 - Article

VL - 45

SP - 898

EP - 905

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 8

ER -